1. Research and Development Aspects of Oral Controlled Release Systems;Qiu,2000
2. Qiu, Y. (2007). Design and Evaluation of Oral Modified-Release Dosage Forms Based on Drug Property and Delivery Technology. Proc. CAE/AAPS/CPA/CRS/FIP/APSTJ Conference: Oral Controlled Release Development and Technology. Shanghai, pp. 34–43.
3. Oxybutynin extended release and tolterodine immediate release;Getsios;Clin. Drug Invest.,2004
4. Guidance for Industry. (1997). SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In vitro Dissolution Testing and In vivo Bioequivalence Documentation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
5. Wise, D.L., Klibanov, A.M., Langer, R., Mikos, A.G., Peppas, N.A., Trantolo, D.J. Wnek, G.E. & Yaszeski, M.J. (eds). Handbook of Pharmaceutical Controlled Release Technology, Marcel Dekker, Inc., New York, NY.